Journal of Enzyme Inhibition and Medicinal Chemistry · 2006 · 12 citations · 29 references
Life SciencesBiochemistryPharmacologyBiochemical PharmacologyEnzyme MechanismMolecular PharmacologyDiabetes Mellitus BiochemistryEnzyme InhibitionEnzyme RegulationRedox EnzymesAgonist ActivityAlcohol OxidationAldo-keto ReductasesCompetitive InhibitionOxidationPeroxisome Proliferator Receptor SignalingPeroxisome Proliferator-activated Receptor SignalingPeroxisome Proliferator-activated Receptors
Aldose reductase (AR) is implicated to play a critical role in diabetes and cardiovascular complications because of the reaction it catalyzes. Our data reveal that peroxisome proliferator WY 14,643, follows a pure non-competitive inhibition pattern in the aldehyde reduction activity as well as in the alcohol oxidation activity of AR. This finding communicates for the first time a novel feature of WY 14,643 in regulating AR activity. In addition, this observation indicates that AR, AR-like proteins and aldo-keto reductase (AKR) members may be involved in the WY 14,643 mechanism of action when it is administered as PPAR agonist.
29
The Progression From Hypertension to Congestive Heart Failure
Daniel Levy · JAMA · 1996 · 2.1K citations
Medicine, Cardiology, Physiology +8
Toshifumi Aoyama, Jeffrey M. Peters, Nobuko Iritani et al. · Journal of Biological Chemistry · 1998 · 861 citations · Full text